About Santen Pharmaceuticals
Santen Pharmaceuticals is a company based in Osaka (Japan) founded in 1890.. Santen Pharmaceuticals has completed 3 acquisitions, including Eyevance, InnFocus and NUSTOTO. Santen Pharmaceuticals offers products and services including Tapcom, Ryjunea, and Rocklatan. Santen Pharmaceuticals operates in a competitive market with competitors including PanTher Therapeutics, PolyPid, Zyl Therapeutics, Lexaria Bioscience and LabInCube, among others.
- Headquarter Osaka, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Santen India Private Limited
- Date of Incorporation 29 Jul, 2011
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$1.31 M (USD)-5.08as on Mar 31, 2022
-
Net Profit
$94.31 K (USD)-23.94as on Mar 31, 2022
-
EBITDA
$132.91 K (USD)45.46as on Mar 31, 2022
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Eyevance
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Santen Pharmaceuticals
Santen Pharmaceuticals offers a comprehensive portfolio of products and services, including Tapcom, Ryjunea, and Rocklatan. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats open-angle glaucoma and ocular hypertension
Slows progression of paediatric myopia
Manages open-angle glaucoma and ocular hypertension
Unlock access to complete
Unlock access to complete
Software Development Team
31 people
Leadership Team
27 people
Human Resources and Administration
18 people
Finance and Accounting
17 people
Head Team
7 people
Product Management Team
7 people
Operations Team
7 people
Sales and Marketing
6 people
Unlock access to complete
Funding Insights of Santen Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Santen Pharmaceuticals
Santen Pharmaceuticals has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Eyevance, InnFocus and NUSTOTO. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of ophthalmic therapy products for ocular surface & anterior segment
|
2017 | ||||
|
Glaucoma is treated via the implantable MicroShunt device in ophthalmology.
|
2003 | ||||
|
NUSTOTO is recognized as a provider of online slot games.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Santen Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Santen Pharmaceuticals Comparisons
Competitors of Santen Pharmaceuticals
Santen Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PanTher Therapeutics, PolyPid, Zyl Therapeutics, Lexaria Bioscience and LabInCube, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| domain | founded_year | HQ Location |
Hydrogel-derived nanoparticles for topical drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
Patented drug delivery technology is developed for bioactive molecules.
|
|
| domain | founded_year | HQ Location |
Drug-releasing medical devices and medicines are developed with InCube technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Santen Pharmaceuticals
Frequently Asked Questions about Santen Pharmaceuticals
When was Santen Pharmaceuticals founded?
Santen Pharmaceuticals was founded in 1890.
Where is Santen Pharmaceuticals located?
Santen Pharmaceuticals is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
What is the annual revenue of Santen Pharmaceuticals?
Annual revenue of Santen Pharmaceuticals is $1.31M as on Mar 31, 2022.
What does Santen Pharmaceuticals do?
Santen Pharmaceuticals was founded in 1890 in Osaka, Japan, where focus is placed on manufacturing pharmaceuticals for ophthalmology and rheumatology sectors. Drugs targeting corneal conjunctival disorders, glaucoma, retinal uvea conditions, ocular infections, and related diseases are developed. Collaborations with Asahi Glass have integrated fluorine synthesis technology for glaucoma advancements. Operations include a drug development pipeline, the Sante Series of eye treatments, medical equipment, and dietary supplements.
Who are the top competitors of Santen Pharmaceuticals?
Santen Pharmaceuticals's top competitors include PanTher Therapeutics, PolyPid and Lexaria Bioscience.
What products or services does Santen Pharmaceuticals offer?
Santen Pharmaceuticals offers Tapcom, Ryjunea, and Rocklatan.